NCT05464628

Drug Interaction Study of ASC42 With Atorvastatin

A Phase 1, Open-Label, Drug-Drug Interaction, Study to Evaluate the Effect of ASC42 on the Pharmacokinetics of Atorvastatin Tablets in Healthy Volunteers (HVs)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Gannex Pharma Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine whether ASC42 alters the pharmacokinetics of atorvastatin in healthy subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Atorvastatin	Atorvastatin followed by ASC42 daily followed by separate co-administration of atorvastatin
DRUG	ASC42	Atorvastatin followed by ASC42 daily followed by separate co-administration of atorvastatin

Timeline

• Start date: 2022-08-08
• Primary completion: 2022-08-23
• Completion: 2022-08-30
• First posted: 2022-07-19
• Last updated: 2024-09-27

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study